Pregled bibliografske jedinice broj: 907496
Cyclodextrin encapsulation of daidzein and genistein by grinding: Implication on the glycosaminoglycan accumulation in mucopolysaccharidosys type II and III fibroblasts
Cyclodextrin encapsulation of daidzein and genistein by grinding: Implication on the glycosaminoglycan accumulation in mucopolysaccharidosys type II and III fibroblasts // Journal of microencapsulation, 35 (2018), 1; 1-12 doi:10.1080/02652048.2017.1409819 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 907496 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Cyclodextrin encapsulation of daidzein and genistein by grinding: Implication on the glycosaminoglycan accumulation in mucopolysaccharidosys type II and III fibroblasts
Autori
Fumić, Barbara ; Jablan, Jasna ; Cinčić, Dominik ; Zovko Končić, Marijana ; Jug, Mario
Izvornik
Journal of microencapsulation (0265-2048) 35
(2018), 1;
1-12
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
daidzein ; genistein ; cyclodextrin ; neat grinding ; glycosaminoglycans
Sažetak
This work was aimed to investigate the potential effect of cyclodextrin encapsulation on intrinsic ability of daidzein (DAD) and genistein (GEN) to inhibit the glycosaminoglycan (GAG) synthesis in fibroblasts originating from patients with mucopolysaccharidoes (MPS), type II and III. DAD or GEN encapsulation with either 2-hydroxypropyl-β-cyclodextrin or sulphobuthylether-β-cyclodextrin were achieved by neat grinding and characterised by thermal analysis, X-ray powder diffraction, scanning electron microscopy and solubility testing, confirming the complexes formation with increased solubility with respect to starting compounds. Both isoflavones, as well as their co-ground cyclodextrin complexes reduced GAG levels in the fibroblasts of MPS II and MPS III patient for 54.8-77.5 %, in a dose dependant manner, without any significant cytotoxic effect. Cyclodextrin encapsulation did not change the intrinsically high effect of both DAD and GEN on the GAG level reduction in the treated cells, thus could be considered as a part of combination therapies of MPS.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Prirodoslovno-matematički fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Mario Jug
(autor)
Marijana Zovko Končić
(autor)
Dominik Cinčić
(autor)
Jasna Jablan
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE